Danaher Corporation announced today that it has set the price for the proposed public offering of 6,000,000 shares of common stock (par value $0.01 per share) at a price to the public of $82.25 per share. Danaher has granted the underwriters a 30-day option to purchase up to an additional 900,000 shares of common stock to cover over-allotments, if any.

Danaher expects to receive net proceeds, after expenses and assuming the underwriters' over-allotment option is not exercised, of approximately $478.0 million. The Company intends to use the net proceeds from this offering to fund, in part, the Company's pending acquisition of Tektronix, Inc., or for general corporate purposes. The offering is expected to close on November 7, 2007.

Merrill Lynch, Pierce, Fenner & Smith Incorporated and Morgan Stanley & Co. Incorporated are acting as joint book-running managers with Lehman Brothers Inc. and UBS Securities LLC acting as co-managers.

The offering is being made pursuant to an effective registration statement filed by Danaher Corporation with the Securities and Exchange Commission on July 14, 2006.

The offering of the common shares may be made only by means of a prospectus. A copy of the prospectus supplement relating to the common shares can be obtained from Merrill Lynch's prospectus department at 4 World Financial Center, New York, NY 10080, telephone: 212-449-1000, from Morgan Stanley at 180 Varick Street 2/F, New York, NY 10014, email: prospectus@morganstanley.com, telephone: 1-866-718-1649, from Lehman Brothers, c/o Broadridge, Integrated Distribution Services, 1155 Long Island Avenue, Edgewood, NY 11717, email: qiana.smith@broadridge.com, facsimile: 631-254-7140, from UBS at 299 Park Avenue, New York, NY 10171, telephone: 212-821-3884.

This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, Danaher's common shares or any other securities, nor shall there be any sale of securities mentioned in this press release in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.

Danaher Corporation is a leading manufacturer of Professional Instrumentation, Medical Technologies, Industrial Technologies and Tools and Components (www.danaher.com).

Statements in this document that are not strictly historical, including the issuance and sale of common shares in the offering, may constitute forward looking statements. There are a number of risks and uncertainties that could cause actual results or events to differ materially from those suggested or indicated by such forward looking statements, including the factors described in Danaher's Annual Report on Form 10-K for the year ended December 31, 2006 and other SEC filings of Danaher. These forward looking statements speak only as of the date of this release and Danaher does not intend to update any forward looking statement except as required by law.

SOURCE: Danaher Corporation